Cargando…

Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate

OBJECTIVE: To describe our clinical experience across the entire range of fetal‐fraction (FF) measurements of a non‐invasive prenatal screen (NIPS) that uses whole‐ genome sequencing (WGS). METHODS: We analyzed retrospectively results from 58 105 singleton pregnancies that underwent NIPS on a custom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hancock, S., Ben‐Shachar, R., Adusei, C., Oyolu, C. B., Evans, E. A., Kang, H. P., Haverty, C., Muzzey, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496885/ https://www.ncbi.nlm.nih.gov/pubmed/31671482 http://dx.doi.org/10.1002/uog.21904

Ejemplares similares

Response to “Noninvasive prenatal screening at low fetal fraction: comparing whole‐genome sequencing and single‐nucleotide polymorphism methods”
por: Muzzey, Dale, et al.
Publicado: (2017)

Reply
por: Hancock, S., et al.
Publicado: (2020)

Re: Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate
por: Jelsema, R., et al.
Publicado: (2020)

Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management
por: Arjunan, Aishwarya, et al.
Publicado: (2020)

The impact of HBB‐related hemoglobinopathies carrier status on fetal fraction in noninvasive prenatal screening
por: Putra, Manesha, et al.
Publicado: (2022)

Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk
por: Muzzey, Dale, et al.
Publicado: (2019)

High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening
por: Welker, Noah C., et al.
Publicado: (2020)

Lipid Metabolism Affects Fetal Fraction and Screen Failures in Non-invasive Prenatal Testing
por: Cao, Jun, et al.
Publicado: (2022)

Calculation of Fetal Fraction for Non-Invasive Prenatal Testing
por: Cserhati, Matthew
Publicado: (2021)

White blood cell count affects fetal fraction and test failure rates in noninvasive prenatal screening
por: Qiao, Longwei, et al.
Publicado: (2023)

Strategies to minimize false positives and interpret novel microdeletions based on maternal copy-number variants in 87,000 noninvasive prenatal screens
por: Kaseniit, Kristjan Eerik, et al.
Publicado: (2018)

Enrichment of the fetal fraction in non-invasive prenatal screening reduces maternal background interference
por: Liang, Bo, et al.
Publicado: (2018)

Inaccuracies and shortcomings in “Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations”
por: Johansen Taber, Katherine, et al.
Publicado: (2019)

Prenatal Diagnosis of Fetal Heart Failure
por: Srisupundit, Kasemsri, et al.
Publicado: (2023)

Correction: Inaccuracies and shortcomings in “Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations”
por: Taber, Katherine Johansen, et al.
Publicado: (2019)

Combination of Fetal Fraction Estimators Based on Fragment Lengths and Fragment Counts in Non-Invasive Prenatal Testing
por: Gazdarica, Juraj, et al.
Publicado: (2019)

Chromosomal phase improves aneuploidy detection in non-invasive prenatal testing at low fetal DNA fractions
por: Genovese, Giulio, et al.
Publicado: (2022)

Fetal fraction‐based risk algorithm for non‐invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell‐free fetal DNA
por: McKanna, T., et al.
Publicado: (2018)

Prenatal and Postnatal Choline Supplementation in Fetal Alcohol Spectrum Disorder
por: Ernst, Abigail M., et al.
Publicado: (2022)

Bioinformatics Approaches for Fetal DNA Fraction Estimation in Noninvasive Prenatal Testing
por: Peng, Xianlu Laura, et al.
Publicado: (2017)

Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review
por: Deng, Cechuan, et al.
Publicado: (2022)

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry
por: Savarese, G., et al.
Publicado: (2020)

A data-driven evaluation of the size and content of expanded carrier screening panels
por: Ben-Shachar, Rotem, et al.
Publicado: (2019)

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
por: Butler, Javed, et al.
Publicado: (2021)

An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study
por: Hu, Ping, et al.
Publicado: (2019)

Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening
por: Dang, Minghao, et al.
Publicado: (2019)

Application of FF-QuantSC for the Precise Estimation of Fetal Fraction in Non-invasive Prenatal Testing in Two SRY-Translocation Cases
por: Zeng, Yan, et al.
Publicado: (2020)

T1 mapping across the ejection fraction spectrum
por: Alaour, Bashir, et al.
Publicado: (2016)

Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting
por: Stolfo, Davide, et al.
Publicado: (2022)

Current approaches on non-invasive prenatal diagnosis: Prenatal genomics, transcriptomics, personalized fetal diagnosis
por: Günel, Tuba, et al.
Publicado: (2014)

Calculating the fetal fraction for noninvasive prenatal testing based on genome‐wide nucleosome profiles
por: Straver, Roy, et al.
Publicado: (2016)

Correction: Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening
por: Dang, Minghao, et al.
Publicado: (2019)

Combined fetal fraction to analyze the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18, and 21
por: Yang, Jiexia, et al.
Publicado: (2023)

Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening
por: Hou, Yaping, et al.
Publicado: (2019)

Effects of Prenatal Exposure to Alcohol and Smoking on Fetal Heart Rate and Movement Regulation
por: Lucchini, Maristella, et al.
Publicado: (2021)

A prenatal case with discrepant findings between non-invasive prenatal testing and fetal genetic testings
por: Pan, Qiong, et al.
Publicado: (2014)

Difficult prenatal diagnosis: fetal coarctation
por: Buyens, A., et al.
Publicado: (2012)

Coronavirus Vaccination Hesitancy: Early Education to Counter Vaccine Hesitancy/Refusal
por: Oyolu, Irene O.
Publicado: (2023)

Regulating non-invasive prenatal testing (NIPT) for fetal sex determination
por: Taylor-Sands, Michelle, et al.
Publicado: (2023)

Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum
por: Gallo, Giovanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fttu8q3pn33ajskusturf913tm